201 related articles for article (PubMed ID: 24955057)
1. Asymptomatic young man with Danon disease.
Kim J; Parikh P; Mahboob M; Arrighi JA; Atalay MK; Rowin EJ; Maron MS
Tex Heart Inst J; 2014 Jun; 41(3):332-4. PubMed ID: 24955057
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience.
Jhaveri S; Herber J; Zahka K; Boyle GJ; Saarel EV; Aziz PF
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1932-1938. PubMed ID: 31240821
[TBL] [Abstract][Full Text] [Related]
3. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.
Zaki A; Zaidi A; Newman WG; Garratt CJ
J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report.
Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M
BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794
[TBL] [Abstract][Full Text] [Related]
5. Danon disease as a cause of autophagic vacuolar myopathy.
Yang Z; Vatta M
Congenit Heart Dis; 2007; 2(6):404-9. PubMed ID: 18377432
[TBL] [Abstract][Full Text] [Related]
6. [Danon disease: a case report and literature overview].
Catović S; Otasević P
Srp Arh Celok Lek; 2007; 135(3-4):197-200. PubMed ID: 17642461
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.
Maron BJ; Roberts WC; Arad M; Haas TS; Spirito P; Wright GB; Almquist AK; Baffa JM; Saul JP; Ho CY; Seidman J; Seidman CE
JAMA; 2009 Mar; 301(12):1253-9. PubMed ID: 19318653
[TBL] [Abstract][Full Text] [Related]
8. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J
Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667
[TBL] [Abstract][Full Text] [Related]
9. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease.
Türkmen H; Uysal F; Bostan ÖM
Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912
[TBL] [Abstract][Full Text] [Related]
10. [Glycogen storage disease: danon syndrome].
Shreĭder EV; Bazaeva EV; Stukalova OV; Saidova MA; Chadin AV; Shirinskiĭ VP; Meshkov AN; Samko AN; Mazygula EP; Boĭtsov SA
Kardiologiia; 2012; 52(1):91-6. PubMed ID: 22304360
[No Abstract] [Full Text] [Related]
11. Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene.
Balmer C; Ballhausen D; Bosshard NU; Steinmann B; Boltshauser E; Bauersfeld U; Superti-Furga A
Eur J Pediatr; 2005 Aug; 164(8):509-14. PubMed ID: 15889279
[TBL] [Abstract][Full Text] [Related]
12. Danon disease: a case report and literature review.
Xu J; Li Z; Liu Y; Zhang X; Niu F; Zheng H; Wang L; Kang L; Wang K; Xu B
Diagn Pathol; 2021 May; 16(1):39. PubMed ID: 33933120
[TBL] [Abstract][Full Text] [Related]
13. Danon disease due to a novel splice mutation in the LAMP2 gene.
Nadeau A; Therrien C; Karpati G; Sinnreich M
Muscle Nerve; 2008 Mar; 37(3):338-42. PubMed ID: 18004770
[TBL] [Abstract][Full Text] [Related]
14. Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation.
Cottinet SL; Bergemer-Fouquet AM; Toutain A; Sabourdy F; Maakaroun-Vermesse Z; Levade T; Chantepie A; Labarthe F
J Inherit Metab Dis; 2011 Apr; 34(2):515-22. PubMed ID: 21161685
[TBL] [Abstract][Full Text] [Related]
15. Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease.
Stokes MB; Taylor AJ; McLean CA; D'Arcy CE; Mariani JA
Int J Cardiol; 2016 Oct; 221():14-6. PubMed ID: 27395820
[No Abstract] [Full Text] [Related]
16. A case report of delayed diagnosis of danon disease: Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene.
Zhang Y; Ren H; Zhou S
Medicine (Baltimore); 2020 Oct; 99(40):e22640. PubMed ID: 33019488
[TBL] [Abstract][Full Text] [Related]
17. A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy.
Xu J; Wang L; Liu X; Dai Q
Mol Genet Genomic Med; 2019 Oct; 7(10):e00941. PubMed ID: 31464081
[TBL] [Abstract][Full Text] [Related]
18. Sudden death associated with danon disease in women.
Miani D; Taylor M; Mestroni L; D'Aurizio F; Finato N; Fanin M; Brigido S; Proclemer A
Am J Cardiol; 2012 Feb; 109(3):406-11. PubMed ID: 22074992
[TBL] [Abstract][Full Text] [Related]
19. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy.
Dougu N; Joho S; Shan L; Shida T; Matsuki A; Uese K; Hirono K; Ichida F; Tanaka K; Nishino I; Inoue H
Circ J; 2009 Feb; 73(2):376-80. PubMed ID: 19057086
[TBL] [Abstract][Full Text] [Related]
20. Cardiac magnetic resonance imaging in Danon disease.
Nucifora G; Miani D; Piccoli G; Proclemer A
Cardiology; 2012; 121(1):27-30. PubMed ID: 22378182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
